Oral Chemo Financial Study #012019 - A Survey and Registry Study of the Cost Coverage and Financial Impact Upon Patients of Targeted Oral Anti-Cancer Medications at a Community Hospital Network
The goal of this study is to collect information on how patients perceive the financial impact of being treated with one of the targeted oral anti-cancer medications. It will also assess, in general, how these medications are paid for or made sufficiently affordable for patients.
Principal Investigator
Aaron H. Chevinsky, MD
Contact
Riverside Cancer Clinical Team
757-534-6890
[email protected]
Locations
Peninsula Cancer Institute
12100 Warwick Blvd. Suite 201
Newport News, VA 23601
Peninsula Cancer Institute
120 King’s Way, Suite 3100
Williamsburg, VA 23185
Peninsula Cancer Institute
7544B Medical Drive
Gloucester, VA 23066
Cancer Specialists of Tidewater
1200 First Colonial Road, #204
Virginia Beach, VA 23454
Cancer Specialists of Tidewater
110-E Wimbledon Square
Chesapeake, VA 23320
Cancer Specialists of Tidewater
5839 Harbour View Blvd., #100
Suffolk, VA 23435
Status
Recruiting
Category
Oncology
Study #